+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prognostic factors of profound idiopathic sudden sensorineural hearing loss



Prognostic factors of profound idiopathic sudden sensorineural hearing loss



European Archives of Oto-Rhino-Laryngology 271(6): 1423-1429



Profound idiopathic sudden sensorineural hearing loss is thought to have a poor prognosis, but few studies have focused on this condition. We aimed to assess the impact of patient factors, audiologic parameters, and salvage intratympanic steroid injection therapy on the prognosis of profound idiopathic sudden sensorineural hearing loss. The demographic, clinical, and audiologic data, degree of hearing recovery, and efficacy of intratympanic steroid injection therapy in 576 patients with profound idiopathic sudden sensorineural hearing loss (mean age 56.2 ± 14.9 years) who had been admitted at four tertiary referral centers between 2000 and 2011 were retrospectively reviewed. The mean hearing level at the initial presentation was 108.1 ± 9.5 dB. Many patients experienced vertigo (52.1%) and tinnitus (77.4%). At the 2-month follow-up, 172 (29.8%) patients showed some degree of hearing recovery, but only 21 (3.6%) patients recovered normal hearing. Further, the 116 patients who had received salvage intratympanic steroid injections showed a better audiologic outcome (improvement, 26.1 ± 24.3 vs. 15.7 ± 22.1 dB; P = 0.000) than those who had not (n = 429). In conclusion, a higher degree of hearing loss at the initial presentation indicates a poorer prognosis. Salvage intratympanic steroid injection therapy may improve the hearing of patients with profound idiopathic sudden sensorineural hearing loss after the failure of systemic steroid therapy.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055210509

Download citation: RISBibTeXText

PMID: 23771280

DOI: 10.1007/s00405-013-2593-y


Related references

Prognostic factors for profound sudden idiopathic sensorineural hearing loss: a multicenter retrospective study. European Archives of Oto-Rhino-Laryngology 274(1): 143-149, 2016

Prognostic Factors for the Hearing Outcome in Patients with Profound Idiopathic Sudden Sensorineural Hearing Loss (Isshl) Receiving the Triple Combined Therapy; 3 Grade 4 ;. Nippon Jibiinkoka Gakkai Kaiho 122(5): 757-763, 2019

Idiopathic sudden sensorineural hearing loss: prognostic factors. Journal of Laryngology and Otology 120(9): 718-724, 2006

Prognostic factors regarding the hearing outcome in severe to profound sudden sensorineural hearing loss treated by tympanotomy and sealing of labyrinthine windows after ineffective systemic corticosteroid application. European Archives of Oto-Rhino-Laryngology 275(7): 1749-1758, 2018

Prognostic factors for patients with the idiopathic sudden sensorineural hearing loss. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 43(9): 660-664, 2008

Different prognostic characteristics between profound sudden sensorineural hearing loss and total sudden hearing loss. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 45(7): 570-573, 2011

Edaravone, a free radical scavenger, in the treatment of idiopathic sudden sensorineural hearing loss with profound hearing loss. Auris, Nasus, Larynx 37(1): 42-46, 2010

Multivariate analysis of prognostic factors for idiopathic sudden sensorineural hearing loss in children. Laryngoscope 125(9): 2209-2215, 2015

Uni- and multivariate models for investigating potential prognostic factors in idiopathic sudden sensorineural hearing loss. European Archives of Oto-Rhino-Laryngology 272(8): 1899-1906, 2015

Outcomes of Severe to Profound Idiopathic Sudden Sensorineural Hearing Loss. Clinical and Experimental Otorhinolaryngology 8(3): 206-210, 2015

Intratympanic dexamethasone for profound idiopathic sudden sensorineural hearing loss. Otolaryngology--Head and Neck Surgery 132(6): 902-905, 2005

Efficacy of Intratympanic Steroid on Idiopathic Sudden Sensorineural Hearing Loss: An Analysis of Cases With Negative Prognostic Factors. American Journal of Audiology 2019: 1-7, 2019

Prognostic factors for idiopathic sudden sensorineural hearing loss treated with hyperbaric oxygen therapy and intravenous steroids. Journal of Laryngology and Otology 131(1): 77-82, 2016

Efficacy and Prognostic Factors of Combined Hyperbaric Oxygen Therapy in Patients With Idiopathic Sudden Sensorineural Hearing Loss. American Journal of Audiology 28(1): 95-100, 2019

Intratympanic steroid administration: use in the treatment of profound idiopathic sudden sensorineural hearing loss. Hno 61(2): 152, 154-8, 2013